Clearside Biomedical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Clearside Biomedical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.69M, a 17% increase year-over-year.
  • Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$31.9M, a 14.6% increase year-over-year.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.5M, a 1.4% increase from 2022.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.9M, a 8863% decline from 2021.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $376K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$31.9M -$7.69M +$1.58M +17% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$33.5M -$7.6M +$1.51M +16.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$35M -$11.8M -$2.48M -26.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$32.5M -$4.83M +$4.83M +50% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$37.3M -$9.27M -$1.44M -18.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$35.9M -$9.11M -$1.29M -16.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$34.6M -$9.28M -$1.64M -21.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$32.9M -$9.66M -$28.4M -152% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$4.58M -$7.83M -$2.94M -60.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.64M -$7.81M -$1.72M -28.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 $83K -$7.64M -$293K -3.99% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 $376K $18.7M +$25.8M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 -$25.4M -$4.89M -$2.45M -101% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$23M -$6.1M -$341K -5.93% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$22.7M -$7.35M -$4.44M -153% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$18.2M -$7.11M -$4.02M -130% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 -$14.2M -$2.43M +$4.1M +62.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.3M -$5.75M -$20K -0.35% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$18.3M -$2.91M +$12.5M +81.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$30.8M -$3.1M +$18.5M +85.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-13
Q3 2019 -$49.3M -$6.54M +$17.3M +72.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$66.6M -$5.73M +$15M +72.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$81.6M -$15.4M +$1.2M +7.24% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$82.8M -$21.6M -$5.15M -31.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$77.7M -$23.9M -$5.54M -30.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-13
Q2 2018 -$72.1M -$20.7M -$6.93M -50.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-13
Q1 2018 -$65.2M -$16.6M -$6.23M -60.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-13
Q4 2017 -$59M -$16.5M -$6.81M -70.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$52.2M -$18.3M -$12.7M -225% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-15
Q2 2017 -$39.5M -$13.8M -$8.67M -170% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-15
Q1 2017 -$30.8M -$10.4M -$4.92M -90.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-15
Q4 2016 -$25.9M -$9.69M -$4.52M -87.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$21.4M -$5.65M -$2.17M -62.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$19.2M -$5.1M +$225K +4.22% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$19.4M -$5.45M -$1.69M -45% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$17.7M -$5.17M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$3.48M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$5.33M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$3.76M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.